Reported Friday, Entero Therapeutics Received Nasdaq Notification For Delayed 10-Q Filing, Plans To Regain Compliance By October Deadline
Portfolio Pulse from Benzinga Newsdesk
Entero Therapeutics has received a notification from Nasdaq regarding a delayed 10-Q filing. The company plans to regain compliance by the October deadline.
August 26, 2024 | 7:20 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Entero Therapeutics has been notified by Nasdaq for a delayed 10-Q filing. The company is working to meet the compliance deadline by October.
The notification from Nasdaq indicates a regulatory issue due to a delayed filing, which can negatively impact investor confidence in the short term. However, the company's plan to regain compliance by October may mitigate long-term effects.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100